Invesco
OLMA icon

Invesco’s Olema Pharmaceuticals OLMA Stock Holding History

Invesco’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.95M Sell
130,933
-24,799
-16% -$552K ﹤0.01% 2556
2025
Q4 		$3.89M Buy
155,732
+31,098
+25% +$553K ﹤0.01% 2359
2025
Q3 		$1.22M Buy
124,634
+44,705
+56% +$268K ﹤0.01% 2839
2025
Q2 		$340K Buy
79,929
+29,119
+57% +$130K ﹤0.01% 3322
2025
Q1 		$191K Buy
50,810
+34,362
+209% +$173K ﹤0.01% 3521
2024
Q4 		$95.9K Buy
16,448
+1,293
+9% +$12.9K ﹤0.01% 3630
2024
Q3 		$181K Sell
15,155
-327
-2% -$4.18K ﹤0.01% 3537
2024
Q2 		$168K Buy
15,482
+491
+3% +$5.33K ﹤0.01% 3671
2024
Q1 		$170K Sell
14,991
-10,809
-42% -$139K ﹤0.01% 3677
2023
Q4 		$362K Sell
25,800
-380,942
-94% -$5.12M ﹤0.01% 3374
2023
Q3 		$5.02M Buy
406,742
+68,725
+20% +$701K ﹤0.01% 2207
2023
Q2 		$3.05M Buy
+338,017
New +$2.04M ﹤0.01% 2480
2021
Q4 		– Sell
-8,263
Closed -$228K – 4087
2021
Q3 		$228K Sell
8,263
-241,314
-97% -$6.51M ﹤0.01% 3757
2021
Q2 		$6.98M Buy
249,577
+3,159
+1% +$89.9K ﹤0.01% 2276
2021
Q1 		$8.18M Sell
246,418
-283,582
-54% -$12.2M ﹤0.01% 2078
2020
Q4 		$25.5M Buy
+530,000
New +$24.9M 0.01% 1310

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Invesco's OLMA Position: Q1 2026 in Review

Invesco reduced its Olema Pharmaceuticals (OLMA) stake by 16% in Q1 2026, selling an estimated $552K and leaving 130,933 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2556.

Invesco first reported a position in OLMA in Q4 2020 and has held it in 16 quarters since. The position peaked at $25.5M in Q4 2020. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Invesco held 130,933 shares of Olema Pharmaceuticals worth $1.95M as of Q1 2026.
  • Invesco sold 24,799 Olema Pharmaceuticals shares in Q1 2026, an estimated $552K.
  • Olema Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2556 holding.
  • Invesco first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 16 quarters since.
  • Invesco's Olema Pharmaceuticals position peaked at $25.5M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.